BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32080809)

  • 21. A Prediction Model for Tumor Recurrence in Stage II-III Colorectal Cancer Patients: From a Machine Learning Model to Genomic Profiling.
    Chen PC; Yeh YM; Lin BW; Chan RH; Su PF; Liu YC; Lee CT; Chen SH; Lin PC
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nomogram Predicting Survival After Recurrence in Patients With Stage I to III Colon Cancer: A Nationwide Multicenter Study.
    Kawai K; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Sugihara K; Watanabe T
    Dis Colon Rectum; 2018 Sep; 61(9):1053-1062. PubMed ID: 30086054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancer.
    Segelman J; Akre O; Gustafsson UO; Bottai M; Martling A
    Colorectal Dis; 2014 May; 16(5):359-67. PubMed ID: 24410859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nomograms to predict survival after colorectal cancer resection without preoperative therapy.
    Zhang ZY; Luo QF; Yin XW; Dai ZL; Basnet S; Ge HY
    BMC Cancer; 2016 Aug; 16(1):658. PubMed ID: 27553083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Less intensive surveillance after radical surgery for stage I-III colorectal cancer by focusing on the doubling time of recurrence.
    Miyake H; Kawai K; Nozawa H; Sasaki K; Kaneko M; Murono K; Emoto S; Ishii H; Sonoda H; Ishihara S
    Surg Today; 2021 Apr; 51(4):550-560. PubMed ID: 32935208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
    Midgley RS; McConkey CC; Johnstone EC; Dunn JA; Smith JL; Grumett SA; Julier P; Iveson C; Yanagisawa Y; Warren B; Langman MJ; Kerr DJ
    J Clin Oncol; 2010 Oct; 28(30):4575-80. PubMed ID: 20837956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life and fear of cancer recurrence in T1 colorectal cancer patients treated with endoscopic or surgical tumor resection.
    Dang H; de Vos Tot Nederveen Cappel WH; van der Zwaan SMS; van den Akker-van Marle ME; van Westreenen HL; Backes Y; Moons LMG; Holman FA; Peeters KCMJ; van der Kraan J; Langers AMJ; Lijfering WM; Hardwick JCH; Boonstra JJ
    Gastrointest Endosc; 2019 Mar; 89(3):533-544. PubMed ID: 30273589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life and risk of colorectal cancer recurrence and All-cause death among advanced stages of colorectal cancer 1-year after diagnosis.
    Wong CK; Law WL; Wan YF; Poon JT; Lam CL
    BMC Cancer; 2014 May; 14():337. PubMed ID: 24886385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer.
    Zhang J; Gong Z; Gong Y; Guo W
    Jpn J Clin Oncol; 2019 May; 49(5):438-446. PubMed ID: 30924498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nomogram for predicting recurrence in stage II colorectal cancer.
    Hoshino N; Hasegawa S; Hida K; Kawada K; Ganeko R; Sugihara K; Sakai Y
    Acta Oncol; 2016 Dec; 55(12):1414-1417. PubMed ID: 27581839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insufficient Lymph Node Sampling in Patients with Colorectal Cancer Perforation is Associated with an Adverse Oncological Outcome.
    Sugawara K; Kawaguchi Y; Nomura Y; Koike D; Nagai M; Tanaka N
    World J Surg; 2017 Jan; 41(1):295-305. PubMed ID: 27464912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic syndrome is a predictor of all site and liver-specific recurrence following primary resection of colorectal cancer: Prospective cohort study of 1006 patients.
    Bhome R; Peppa N; Karar S; McDonnell D; Mirnezami A; Hamady Z
    Eur J Surg Oncol; 2021 Jul; 47(7):1623-1628. PubMed ID: 33483238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New and Recurrent Colorectal Cancers After Resection: a Systematic Review and Meta-analysis of Endoscopic Surveillance Studies.
    Fuccio L; Rex D; Ponchon T; Frazzoni L; Dinis-Ribeiro M; Bhandari P; Dekker E; Pellisè M; Correale L; van Hooft J; Jover R; Libanio D; Radaelli F; Alfieri S; Bazzoli F; Senore C; Regula J; Seufferlein T; Rösch T; Sharma P; Repici A; Hassan C
    Gastroenterology; 2019 Apr; 156(5):1309-1323.e3. PubMed ID: 30553914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcomes of locally or radically resected T1 colorectal cancer.
    Nam MJ; Han KS; Kim BC; Hong CW; Sohn DK; Chang HJ; Kim MJ; Kim SY; Baek JY; Park SC; Oh JH
    Colorectal Dis; 2016 Sep; 18(9):852-60. PubMed ID: 26589573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nomograms for predicting the prognosis of stage IV colorectal cancer after curative resection: a multicenter retrospective study.
    Kawai K; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Miyata H; Sugihara K; Watanabe T
    Eur J Surg Oncol; 2015 Apr; 41(4):457-65. PubMed ID: 25697470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
    Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
    J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors for distant recurrence of colorectal cancer in patients after curative resection for stage I-III colorectal cancer in Australia.
    Prabhakaran S; Kong JC; Chin M; Carne P; Farmer C; Skinner S; Warrier SK; Bell S
    Langenbecks Arch Surg; 2021 Dec; 406(8):2789-2796. PubMed ID: 34338847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of More vs Less Frequent Follow-up Testing on Overall and Colorectal Cancer-Specific Mortality in Patients With Stage II or III Colorectal Cancer: The COLOFOL Randomized Clinical Trial.
    Wille-Jørgensen P; Syk I; Smedh K; Laurberg S; Nielsen DT; Petersen SH; Renehan AG; Horváth-Puhó E; Påhlman L; Sørensen HT;
    JAMA; 2018 May; 319(20):2095-2103. PubMed ID: 29800179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.